NCT02316795View on ClinicalTrials.gov

Fluorescence Imaging in Sentinel Lymph Node Biopsy for Breast Cancer and Melanoma

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

June 30, 2015

Study Completion Date

December 31, 2015

Conditions
Breast CancerCancer of BreastCancer of the BreastMelanomaMalignant Melanoma
Interventions
PROCEDURE

Sentinel lymph node biopsy

DEVICE

Goggle-based device with light-emitting diodes (LED)

DRUG

Indocynanine Green

This is a infrared fluorescence imaging contrast agent

Trial Locations (1)

63110

Washington University School of Medicine, St Louis

All Listed Sponsors
lead

Washington University School of Medicine

OTHER

NCT02316795 - Fluorescence Imaging in Sentinel Lymph Node Biopsy for Breast Cancer and Melanoma | Biotech Hunter | Biotech Hunter